Explore

Trendline Trendline
Biogen Advances Alzheimer's Drug Diranersen Despite Phase 2 Trial Setback

Biogen Advances Alzheimer's Drug Diranersen Despite Phase 2 Trial Setback

Biogen Advances Alzheimer's Drug Diranersen Despite Phase 2 Trial Setback
Trendline Trendline
Biogen Advances Alzheimer's Drug Diranersen to Phase 3 Despite Phase 2 Challenges

Biogen Advances Alzheimer's Drug Diranersen to Phase 3 Despite Phase 2 Challenges

Biogen Advances Alzheimer's Drug Diranersen to Phase 3 Despite Phase 2 Challenges
Trendline Trendline
Biogen's Alzheimer's Drug Diranersen Moves to Phase 3 Despite Phase 2 Setbacks

Biogen's Alzheimer's Drug Diranersen Moves to Phase 3 Despite Phase 2 Setbacks

Biogen's Alzheimer's Drug Diranersen Moves to Phase 3 Despite Phase 2 Setbacks
Trendline Trendline
Biogen Advances Tau-Targeting Alzheimer's Therapy to Phase 3 Despite Mid-Stage Trial Challenges

Biogen Advances Tau-Targeting Alzheimer's Therapy to Phase 3 Despite Mid-Stage Trial Challenges

Biogen Advances Tau-Targeting Alzheimer's Therapy to Phase 3 Despite Mid-Stage Trial Challenges
Trendline Trendline
Biogen Advances Tau Alzheimer's Therapy to Phase 3 Despite Mid-Stage Setback

Biogen Advances Tau Alzheimer's Therapy to Phase 3 Despite Mid-Stage Setback

Biogen Advances Tau Alzheimer's Therapy to Phase 3 Despite Mid-Stage Setback
Trendline Trendline
Kariya Pharmaceuticals and NeuraLight Collaborate on Brain-Focused GLP-1 Therapeutics for Neurodegenerative Diseases

Kariya Pharmaceuticals and NeuraLight Collaborate on Brain-Focused GLP-1 Therapeutics for Neurodegenerative Diseases

Kariya Pharmaceuticals and NeuraLight Collaborate on Brain-Focused GLP-1 Therapeutics for Neurodegenerative Diseases
Trendline Trendline
Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials

Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials

Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials
Trendline Trendline
PureTech to Present Deupirfenidone Program at American Thoracic Society Conference, Aiming to Transform IPF Treatment

PureTech to Present Deupirfenidone Program at American Thoracic Society Conference, Aiming to Transform IPF Treatment

PureTech to Present Deupirfenidone Program at American Thoracic Society Conference, Aiming to Transform IPF Treatment
Trendline Trendline
Immunome Advances Cancer Therapy Pipeline with New Drug Application and Clinical Trials

Immunome Advances Cancer Therapy Pipeline with New Drug Application and Clinical Trials

Immunome Advances Cancer Therapy Pipeline with New Drug Application and Clinical Trials
Trendline Trendline
Kariya and NeuraLight Collaborate on Brain-Focused GLP-1 Therapies for Neurodegenerative Diseases

Kariya and NeuraLight Collaborate on Brain-Focused GLP-1 Therapies for Neurodegenerative Diseases

Kariya and NeuraLight Collaborate on Brain-Focused GLP-1 Therapies for Neurodegenerative Diseases
Trendline Trendline
Kariya and NeuraLight Collaborate on Brain-Focused GLP-1 Therapies

Kariya and NeuraLight Collaborate on Brain-Focused GLP-1 Therapies

Kariya and NeuraLight Collaborate on Brain-Focused GLP-1 Therapies
Trendline Trendline
Fosun Pharma and AriBio Sign Agreement for Alzheimer's Drug Development

Fosun Pharma and AriBio Sign Agreement for Alzheimer's Drug Development

Fosun Pharma and AriBio Sign Agreement for Alzheimer's Drug Development